AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.

# AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb The companies have discussed a potential merger over several months, the Financial Times reported on Sunday. **Read the full article:** [CNBC](https://www.cnbc.com/2026/08/03/astrazeneca-bristol-myers-squibb-merger-talks.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*